Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q6U4
Term | Name | Level | Count |
---|---|---|---|
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 9 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008380 | RNA splicing | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000213 | tRNA-intron endonuclease activity | 6 | 1 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004519 | endonuclease activity | 5 | 1 |
GO:0004521 | RNA endonuclease activity | 5 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 1 |
GO:0004549 | tRNA-specific ribonuclease activity | 5 | 1 |
GO:0005488 | binding | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016892 | RNA endonuclease activity, producing 3'-phosphomonoesters | 6 | 1 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 6 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 129 | 133 | PF00656 | 0.583 |
CLV_C14_Caspase3-7 | 34 | 38 | PF00656 | 0.568 |
CLV_C14_Caspase3-7 | 72 | 76 | PF00656 | 0.643 |
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.570 |
CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.639 |
CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.617 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.570 |
CLV_PCSK_KEX2_1 | 55 | 57 | PF00082 | 0.669 |
CLV_PCSK_PC1ET2_1 | 55 | 57 | PF00082 | 0.767 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.670 |
DEG_SCF_FBW7_2 | 170 | 177 | PF00400 | 0.549 |
DOC_CKS1_1 | 171 | 176 | PF01111 | 0.551 |
DOC_CYCLIN_yCln2_LP_2 | 15 | 21 | PF00134 | 0.538 |
DOC_MAPK_MEF2A_6 | 36 | 44 | PF00069 | 0.444 |
DOC_MAPK_RevD_3 | 40 | 55 | PF00069 | 0.469 |
DOC_PP4_FxxP_1 | 146 | 149 | PF00568 | 0.636 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.421 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.770 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.427 |
DOC_USP7_MATH_1 | 96 | 100 | PF00917 | 0.558 |
DOC_USP7_UBL2_3 | 55 | 59 | PF12436 | 0.568 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.538 |
DOC_WW_Pin1_4 | 145 | 150 | PF00397 | 0.534 |
DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.541 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.635 |
LIG_14-3-3_CanoR_1 | 10 | 16 | PF00244 | 0.535 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.568 |
LIG_14-3-3_CanoR_1 | 160 | 170 | PF00244 | 0.420 |
LIG_BRCT_BRCA1_1 | 31 | 35 | PF00533 | 0.772 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.564 |
LIG_LIR_Apic_2 | 144 | 149 | PF02991 | 0.635 |
LIG_LIR_Gen_1 | 47 | 53 | PF02991 | 0.683 |
LIG_LIR_Nem_3 | 47 | 51 | PF02991 | 0.735 |
LIG_SH2_STAP1 | 183 | 187 | PF00017 | 0.586 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.537 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.684 |
LIG_SH3_3 | 15 | 21 | PF00018 | 0.538 |
LIG_SH3_3 | 168 | 174 | PF00018 | 0.528 |
LIG_SUMO_SIM_anti_2 | 151 | 157 | PF11976 | 0.493 |
LIG_SUMO_SIM_anti_2 | 41 | 47 | PF11976 | 0.609 |
MOD_CDC14_SPxK_1 | 97 | 100 | PF00782 | 0.628 |
MOD_CDK_SPK_2 | 170 | 175 | PF00069 | 0.475 |
MOD_CDK_SPxK_1 | 94 | 100 | PF00069 | 0.631 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.539 |
MOD_CK1_1 | 148 | 154 | PF00069 | 0.490 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.509 |
MOD_CK2_1 | 105 | 111 | PF00069 | 0.526 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.486 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.516 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.743 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.622 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.535 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.506 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.540 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.738 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.532 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.611 |
MOD_N-GLC_2 | 163 | 165 | PF02516 | 0.465 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.538 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.493 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.499 |
MOD_OFUCOSY | 159 | 165 | PF10250 | 0.447 |
MOD_PKA_1 | 166 | 172 | PF00069 | 0.504 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.550 |
MOD_Plk_2-3 | 127 | 133 | PF00069 | 0.593 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.511 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.504 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.664 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.539 |
MOD_ProDKin_1 | 145 | 151 | PF00069 | 0.529 |
MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.544 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.631 |
MOD_SUMO_for_1 | 174 | 177 | PF00179 | 0.514 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.662 |
TRG_ER_diArg_1 | 51 | 54 | PF00400 | 0.622 |
TRG_ER_diArg_1 | 89 | 92 | PF00400 | 0.459 |
TRG_NLS_MonoCore_2 | 54 | 59 | PF00514 | 0.705 |
TRG_NLS_MonoExtC_3 | 53 | 58 | PF00514 | 0.715 |
TRG_NLS_MonoExtN_4 | 52 | 59 | PF00514 | 0.708 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4G2 | Leptomonas seymouri | 54% | 100% |
A0A3S7X3W7 | Leishmania donovani | 94% | 100% |
A4HIT3 | Leishmania braziliensis | 79% | 100% |
A4I635 | Leishmania infantum | 94% | 100% |
C9ZRF4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
E9B1C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |